S
SomaLogic
Unlocking protein biomarkers to transform healthcare
At a glance
- Founded
- 2000
- Headquarters
- Boulder, United States
- Listing
- Public via SPAC 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- PIProQuest Investments
- DCdRx Capital
Series B and later24 investors entered at this stage
- UBUniversity of Colorado Boulder
- ASAssociates
Casdin Capital- RGRedmile Group
- NONovartis
- BPBoston Millennia Partners
- MMMonashee Investment Management
- LCLogos Capital
- OPOtsuka Pharmaceutical
Janus Henderson Investors
- AMAmgen
Foresite Capital- FMFarallon Capital Management
iCarbonX- MMMillennium Management
T. Rowe Price- MMMadryn Asset Management
- NENec
- QDQuest Diagnostics
- RVReimagined Ventures
- SCSoleus Capital
- IVIntermountain Ventures
- ZPZiff Capital Partners
- RPRevelation Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former SomaLogic employees who went on to found companies, sorted by Dealroom signal score.
Ashwin GopinathUnited States
CUCulminationEst. 2022
FBFront Range BiosciencesEst. 2015
Jonathan VaughtUnited States
FDForesight DiagnosticsEst. 2020
Jake ChabonUnited States
MBMosaic BiosciencesEst. 2009
Marty StantonUnited StatesGlobal footprint
team presence
across markets
Patents
82 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about SomaLogic on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SomaLogic on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.